Abstract
Only 6% to 8% of U.S. cancer patients participate in a clinical trial despite NCCN guidelines recommending trial consideration for all patients as part of a high-quality standard of care. To better understand health system and patient level factors impacting trial enrollment we looked at real-world clinical data from a network of community cancer centers and patient reported data from a personalized trial navigation program.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
